MetLife (MET) CEO gets stock awards and withholds shares for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
MetLife Inc President & CEO Michel Khalaf reported stock-based compensation and related tax withholding. He acquired 69,286 shares of common stock through a restricted stock unit award under MetLife’s 2025 Stock and Incentive Compensation Plan and 81,364 shares from the payout of a 2023–2025 performance share award.
To cover tax obligations on the performance share payout, 43,004 shares were withheld at a price of $75.34 per share, treated as a disposition for tax withholding purposes rather than an open-market sale. After these transactions, Khalaf directly owned 720,129 shares of MetLife common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Khalaf Michel
Role
President & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 69,286 | $0.00 | -- |
| Grant/Award | Common Stock | 81,364 | $0.00 | -- |
| Tax Withholding | Common Stock | 43,004 | $75.34 | $3.24M |
Holdings After Transaction:
Common Stock — 681,769 shares (Direct)
Footnotes (1)
- Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. Shares acquired from the determination of the performance factor for and payout of 2023-2025 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.
FAQ
What did MetLife (MET) CEO Michel Khalaf report in this Form 4 filing?
Michel Khalaf reported stock-based compensation transactions, including new share awards and tax withholding. He received restricted stock units and performance share payout shares, then had some shares withheld to satisfy tax obligations, ending with direct ownership of 720,129 MetLife common shares.
Which MetLife compensation plans are involved in Michel Khalaf’s Form 4 transactions?
The transactions involve MetLife’s 2025 Stock and Incentive Compensation Plan and the 2015 Stock and Incentive Compensation Plan. One award is a restricted stock unit grant under the 2025 plan, and the other is a 2023–2025 performance share payout under the 2015 plan.